Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cardiac MRI Less Invasive Diagnostic Tool for Early Evaluation of Patients with Acute Chest Pain

By HospiMedica International staff writers
Posted on 22 Jun 2023

Every year, around three million patients seek help from emergency departments due to acute chest pain accompanied by mildly increased levels of troponin, a protein that indicates heart muscle damage typically from a heart attack. More...

The optimal strategy for evaluating and managing patients with chest pain and detectable or slightly elevated troponin levels remains uncertain. Although angiography, an invasive procedure used to examine the health and blood flow of blood vessels, is often employed, its invasive nature, such as in cardiac catheterization where a catheter is guided to the heart through a blood vessel, can be problematic. Now, a new study indicates that cardiac magnetic resonance imaging (MRI) is a valuable and safe method for assessing these complex cases.

In the study conducted by researchers at Wake Forest University School of Medicine (Winston-Salem, NC, USA) 312 participants across four U.S. sites were randomly assigned to either cardiac MRI or more invasive interventions, with modifications as required based on evolving conditions. Participants, with an average age of 61 and comprised of 60% men, 64% white, and 34% Black, were monitored for approximately 2.8 years. All participants had acute chest pain and troponin levels ranging from detectable to 1.0 ng/ml. The research team tracked heart attacks, deaths, and instances of cardiac-related hospital readmission or emergency visits.

The researchers found no difference in clinical or safety event rates between the cardiac MRI and the invasive-based care pathway. Furthermore, they discovered that the use of cardiac MRI reduced the requirement for invasive angiography over the prolonged follow-up period. Among the cardiac MRI group, 58% of the participants were safely discharged based on negative imaging results, avoiding angiography or interventions such as revascularization (a treatment to restore blood flow to a blocked section of the heart) within 90 days.

“Patients who present to the emergency room with chest pain and mildly elevated troponin often fall into a diagnostic gray zone,” said Chad Miller, M.D., professor and chair of emergency medicine at Wake Forest University School of Medicine and emergency medicine physician at Atrium Health Wake Forest Baptist. “These findings confirm that cardiac MRI is a highly accurate test that can be reliably used as first-line testing in this complex patient population.”

Related Links:
Wake Forest University School of Medicine


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.